An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern

Yue Zhi Lin, Rong Xian Shen, Zhen Ying Zhu, Xi Lin Deng, Xue Zhi Cao, Xue Feng Wang, Jian Ma, Cheng Gang Jiang, Li Ping Zhao, Xiao Ling Lv, Yi Ming Shao, Jian Hua Zhou

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The EIAV (equine infectious anemia virus) multi-species attenuated vaccine EIAV DLV121 successfully prevented the spread of equine infectious anemia (EIA) in China in the 1970s and provided an excellent model for the study of protective immunity to lentiviruses. In this study, we compared immune responses induced by EIAV DLV121 to immunity elicited by the virulent EIAV LN40 strain and correlated immune responses to protection from infection. Horses were randomly grouped and inoculated with either EIAV DLV121 (Vaccinees, Vac) or a sublethal dose of EIAV LN40 (asymptomatic carriers, Car). Car horses became EIAV LN40 carriers without disease symptoms. Two of the four Vac horses were protected against infection and the other two had delayed onset or reduced severity of EIA with a lethal EIAV LN40 challenge 5.5months post initial inoculation. In contrast, all three Car animals developed acute EIA and two succumbed to death. Specific humoral and cellular immune responses in both Vac and Car groups were evaluated for potential correlations with protection. These analyses revealed that although plasma viral loads remained between 10 3 and 10 5copies/ml for both groups before EIAV LN40 challenge, Vac-treated animals developed significantly higher levels of conformational dependent, Env-specific antibody, neutralizing antibody as well as significantly elevated CD4 + T cell proliferation and IFN-γ-secreting CD8 + T cells than those observed in EIAV LN40 asymptomatic carriers. Further analysis of protected and unprotected cases in vaccinated horses identified that cellular response parameters and the reciprocal anti-p26-specific antibody titers closely correlated with protection against infection with the pathogenic EIAV LN40. These data provide a better understanding of protective immunity to lentiviruses.

Original languageEnglish (US)
Pages (from-to)292-304
Number of pages13
JournalAntiviral Research
Volume92
Issue number2
DOIs
StatePublished - Nov 1 2011

Fingerprint

Equine infectious anemia virus
Vaccines
Equine Infectious Anemia
Horses
Immunity
Lentivirus
Infection
T-Lymphocytes
Attenuated Vaccines
Antibodies
Humoral Immunity
Neutralizing Antibodies
Viral Load
Cellular Immunity
China

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Virology

Keywords

  • EIAV
  • Immune response
  • Vaccine

Cite this

Lin, Yue Zhi ; Shen, Rong Xian ; Zhu, Zhen Ying ; Deng, Xi Lin ; Cao, Xue Zhi ; Wang, Xue Feng ; Ma, Jian ; Jiang, Cheng Gang ; Zhao, Li Ping ; Lv, Xiao Ling ; Shao, Yi Ming ; Zhou, Jian Hua. / An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. In: Antiviral Research. 2011 ; Vol. 92, No. 2. pp. 292-304.
@article{4e94da29080143c282bf87e944e85b4f,
title = "An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern",
abstract = "The EIAV (equine infectious anemia virus) multi-species attenuated vaccine EIAV DLV121 successfully prevented the spread of equine infectious anemia (EIA) in China in the 1970s and provided an excellent model for the study of protective immunity to lentiviruses. In this study, we compared immune responses induced by EIAV DLV121 to immunity elicited by the virulent EIAV LN40 strain and correlated immune responses to protection from infection. Horses were randomly grouped and inoculated with either EIAV DLV121 (Vaccinees, Vac) or a sublethal dose of EIAV LN40 (asymptomatic carriers, Car). Car horses became EIAV LN40 carriers without disease symptoms. Two of the four Vac horses were protected against infection and the other two had delayed onset or reduced severity of EIA with a lethal EIAV LN40 challenge 5.5months post initial inoculation. In contrast, all three Car animals developed acute EIA and two succumbed to death. Specific humoral and cellular immune responses in both Vac and Car groups were evaluated for potential correlations with protection. These analyses revealed that although plasma viral loads remained between 10 3 and 10 5copies/ml for both groups before EIAV LN40 challenge, Vac-treated animals developed significantly higher levels of conformational dependent, Env-specific antibody, neutralizing antibody as well as significantly elevated CD4 + T cell proliferation and IFN-γ-secreting CD8 + T cells than those observed in EIAV LN40 asymptomatic carriers. Further analysis of protected and unprotected cases in vaccinated horses identified that cellular response parameters and the reciprocal anti-p26-specific antibody titers closely correlated with protection against infection with the pathogenic EIAV LN40. These data provide a better understanding of protective immunity to lentiviruses.",
keywords = "EIAV, Immune response, Vaccine",
author = "Lin, {Yue Zhi} and Shen, {Rong Xian} and Zhu, {Zhen Ying} and Deng, {Xi Lin} and Cao, {Xue Zhi} and Wang, {Xue Feng} and Jian Ma and Jiang, {Cheng Gang} and Zhao, {Li Ping} and Lv, {Xiao Ling} and Shao, {Yi Ming} and Zhou, {Jian Hua}",
year = "2011",
month = "11",
day = "1",
doi = "10.1016/j.antiviral.2011.08.016",
language = "English (US)",
volume = "92",
pages = "292--304",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "2",

}

An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. / Lin, Yue Zhi; Shen, Rong Xian; Zhu, Zhen Ying; Deng, Xi Lin; Cao, Xue Zhi; Wang, Xue Feng; Ma, Jian; Jiang, Cheng Gang; Zhao, Li Ping; Lv, Xiao Ling; Shao, Yi Ming; Zhou, Jian Hua.

In: Antiviral Research, Vol. 92, No. 2, 01.11.2011, p. 292-304.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern

AU - Lin, Yue Zhi

AU - Shen, Rong Xian

AU - Zhu, Zhen Ying

AU - Deng, Xi Lin

AU - Cao, Xue Zhi

AU - Wang, Xue Feng

AU - Ma, Jian

AU - Jiang, Cheng Gang

AU - Zhao, Li Ping

AU - Lv, Xiao Ling

AU - Shao, Yi Ming

AU - Zhou, Jian Hua

PY - 2011/11/1

Y1 - 2011/11/1

N2 - The EIAV (equine infectious anemia virus) multi-species attenuated vaccine EIAV DLV121 successfully prevented the spread of equine infectious anemia (EIA) in China in the 1970s and provided an excellent model for the study of protective immunity to lentiviruses. In this study, we compared immune responses induced by EIAV DLV121 to immunity elicited by the virulent EIAV LN40 strain and correlated immune responses to protection from infection. Horses were randomly grouped and inoculated with either EIAV DLV121 (Vaccinees, Vac) or a sublethal dose of EIAV LN40 (asymptomatic carriers, Car). Car horses became EIAV LN40 carriers without disease symptoms. Two of the four Vac horses were protected against infection and the other two had delayed onset or reduced severity of EIA with a lethal EIAV LN40 challenge 5.5months post initial inoculation. In contrast, all three Car animals developed acute EIA and two succumbed to death. Specific humoral and cellular immune responses in both Vac and Car groups were evaluated for potential correlations with protection. These analyses revealed that although plasma viral loads remained between 10 3 and 10 5copies/ml for both groups before EIAV LN40 challenge, Vac-treated animals developed significantly higher levels of conformational dependent, Env-specific antibody, neutralizing antibody as well as significantly elevated CD4 + T cell proliferation and IFN-γ-secreting CD8 + T cells than those observed in EIAV LN40 asymptomatic carriers. Further analysis of protected and unprotected cases in vaccinated horses identified that cellular response parameters and the reciprocal anti-p26-specific antibody titers closely correlated with protection against infection with the pathogenic EIAV LN40. These data provide a better understanding of protective immunity to lentiviruses.

AB - The EIAV (equine infectious anemia virus) multi-species attenuated vaccine EIAV DLV121 successfully prevented the spread of equine infectious anemia (EIA) in China in the 1970s and provided an excellent model for the study of protective immunity to lentiviruses. In this study, we compared immune responses induced by EIAV DLV121 to immunity elicited by the virulent EIAV LN40 strain and correlated immune responses to protection from infection. Horses were randomly grouped and inoculated with either EIAV DLV121 (Vaccinees, Vac) or a sublethal dose of EIAV LN40 (asymptomatic carriers, Car). Car horses became EIAV LN40 carriers without disease symptoms. Two of the four Vac horses were protected against infection and the other two had delayed onset or reduced severity of EIA with a lethal EIAV LN40 challenge 5.5months post initial inoculation. In contrast, all three Car animals developed acute EIA and two succumbed to death. Specific humoral and cellular immune responses in both Vac and Car groups were evaluated for potential correlations with protection. These analyses revealed that although plasma viral loads remained between 10 3 and 10 5copies/ml for both groups before EIAV LN40 challenge, Vac-treated animals developed significantly higher levels of conformational dependent, Env-specific antibody, neutralizing antibody as well as significantly elevated CD4 + T cell proliferation and IFN-γ-secreting CD8 + T cells than those observed in EIAV LN40 asymptomatic carriers. Further analysis of protected and unprotected cases in vaccinated horses identified that cellular response parameters and the reciprocal anti-p26-specific antibody titers closely correlated with protection against infection with the pathogenic EIAV LN40. These data provide a better understanding of protective immunity to lentiviruses.

KW - EIAV

KW - Immune response

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=80054863379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054863379&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2011.08.016

DO - 10.1016/j.antiviral.2011.08.016

M3 - Article

C2 - 21893100

AN - SCOPUS:80054863379

VL - 92

SP - 292

EP - 304

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 2

ER -